Invion (FRA:7C8) Accounts Payable : €0.38 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Invion Accounts Payable?

Invion's Accounts Payable for the quarter that ended in Dec. 2024 was €0.38 Mil.

Invion's quarterly Accounts Payable increased from Dec. 2023 (€0.26 Mil) to Jun. 2024 (€0.45 Mil) but then declined from Jun. 2024 (€0.45 Mil) to Dec. 2024 (€0.38 Mil).

Invion's annual Accounts Payable increased from Jun. 2022 (€0.15 Mil) to Jun. 2023 (€0.25 Mil) and increased from Jun. 2023 (€0.25 Mil) to Jun. 2024 (€0.45 Mil).

Invion Accounts Payable Historical Data

The historical data trend for Invion's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion Accounts Payable Chart

Invion Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable

Get a 7-Day Free Trial

0.07

0.29

0.15

0.25

0.45

Invion Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable	Get a 7-Day Free Trial															0.38	0.25	0.26	0.45	0.38

Invion Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Invion Accounts Payable Related Terms

Thank you for viewing the detailed overview of Invion's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Invion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (FRA:7C8) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

IVIXF:USA IVX:Australia

Address

692 High Street, East Kew, VIC, AUS, 3102

Website

https://www.inviongroup.com

Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines